Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 7,981–8,000 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass II

EDTA 1% Sterile Injection (Preservative Free), Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Lidocaine 1%/Dextrose 12.5% (PF) Injection, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Neomycin 40 mg/Polymixin B 200,000 Bladder Irrigation Solution, 1000 mL bottle, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Prostaglandin Tri-Mix 60:30:1 Injection, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Interferon 1 Million IU/mL Eye Drops, 1 mL Droptainer, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Serum Tears 50% Ophthalmic Drops, 1 mL Dropper, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Methylcobalamin 3000 mcg/mL Injection Solution, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Vitamin D3 200,000 IU/mL Injection, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Testosterone Cypionate 250 mg/mL Sterile Injection, 5 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Bacitracin 3000U/30 mL Irrigation, 30 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Streptomycin 24 mg/Dexamethasone 10 mg/mL Otic Injection, 1 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Serum Tears 30% Drops, 1 mL Droptainer, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Serum Tears 20% Drops, 1 mL Droptainer, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sermorelin 0.4 mg/0.5 mL, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Sermorelin 0.3 mg/0.5 mL, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Prostaglandin Tri-Mix 50:30:1, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Prostaglandin Tri-Mix 20:30:1, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Prostaglandin Quad with Atropine 10:30:1:0.15, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Prostaglandin Quad-Mix 20:30:1:0.15 Injection, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Prostaglandin 60 mcg/mL, Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.